Literature DB >> 26097545

Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.

Xue-Ling Kang1, Hong Zou2, Li Juan Pang3, Wen Hao Hu3, Jin Zhao3, Yan Qi3, Chun-Xia Liu3, Jian Ming Hu3, Jing-Xia Tang4, Hong An Li3, Wei Hua Liang3, Xiang-Lin Yuan5, Feng Li2.   

Abstract

Renal cell carcinoma (RCC) accounts for approximately 3% of all new cancer cases. Although the classification of RCC is based mainly on histology, this method is not always accurate. We applied comparative genomic hybridization (CGH) to determine genomic alterations in 46 cases of different RCC histological subtypes [10 cases of clear cell RCC (CCRCC), 13 cases of papillary RCC (PRCC), 12 cases of chromophobe RCC (CRCC), 9 cases of Xp11.2 translocation RCC (Xp11.2RCC), 2 cases of undifferentiated RCC (unRCC)], and investigated the relationships between clinical parameters and genomic aberrations. Changes involving one or more regions of the genome were seen in all RCC patients; DNA sequence gains were most frequently (>30%) seen in chromosomes 7q, 16p, and 20q; losses from 1p, 3p, 13q, 14q, and 8p. We conclude CGH is a useful complementary method for differential diagnosis of RCC. Loss of 3p21-25, 15q, and gain of 16p11-13 are relatively particular to CCRCC vs. other types of RCC. Gain of 7p13-22, 8q21-24, and loss of 18q12-ter, 14q13-24, and Xp11-q13/Y are more apparent in PRCC, and gain of 8q21-24 is characteristic of type 2 PRCC vs. type 1 PRCC. Loss of 2q12-32, 10p12-15, and 11p11-15, 13p are characteristic of CRCC, and gain of 3p and loss of 11p11-15 and 13p are significant differentiators between common CRCC and CRCC accompanied by sarcomatous change groups. Gain of Xp11-12 is characteristic of the Xp11.2RCC group. Based on Multivariate Cox regression analysis, aberration in 5 chromosome regions were poor prognostic markers of RCC, and include the gain of chromosome 12p12-ter (P = 0.034, RR = 3.502, 95% CI 1.097-11.182), 12q14-ter (P = 0.002, RR = 5.115, 95% CI 1.847-14.170), 16q21-24 (P = 0.044, RR = 2.629, 95% CI 1.027-6.731), 17p12-ter (P = 0.017, RR = 3.643, 95% CI 1.262-10.512) and the loss of 18q12-23 (P = 0.049, RR = 2.911, 95% CI 1.006-8.425), which may provide clues of new genes involved in RCC tumorigenesis.

Entities:  

Keywords:  Renal cell carcinoma; chromosomal change; comparative genomic hybridization

Mesh:

Year:  2015        PMID: 26097545      PMCID: PMC4466932     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  43 in total

Review 1.  The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.

Authors:  Wendy C Burns; Merlin C Thomas
Journal:  Expert Rev Mol Med       Date:  2010-05-27       Impact factor: 5.600

2.  TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.

Authors:  Donghao Shang; Yuting Liu; Peiqian Yang; Yongqian Chen; Ye Tian
Journal:  Urology       Date:  2012-02-15       Impact factor: 2.649

Review 3.  Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.

Authors:  Maxine Sun; Shahrokh F Shariat; Christopher Cheng; Vincenzo Ficarra; Masaru Murai; Stéphane Oudard; Allan J Pantuck; Richard Zigeuner; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2011-06-30       Impact factor: 20.096

4.  Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis.

Authors:  Shuji Mikami; Ken-Ichi Katsube; Mototsugu Oya; Masaru Ishida; Takeo Kosaka; Ryuichi Mizuno; Makio Mukai; Yasunori Okada
Journal:  Lab Invest       Date:  2011-08-01       Impact factor: 5.662

Review 5.  Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects.

Authors:  N Kuroda; M Toi; M Hiroi; H Enzan
Journal:  Histol Histopathol       Date:  2003-04       Impact factor: 2.303

6.  Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.

Authors:  Firat Baytekin; Burcin Tuna; Ugur Mungan; Guven Aslan; Kutsal Yorukoglu
Journal:  Urol Oncol       Date:  2009-11-27       Impact factor: 3.498

7.  High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.

Authors:  T Yoshimoto; K Matsuura; S Karnan; H Tagawa; C Nakada; M Tanigawa; Y Tsukamoto; T Uchida; K Kashima; S Akizuki; I Takeuchi; F Sato; H Mimata; M Seto; M Moriyama
Journal:  J Pathol       Date:  2007-12       Impact factor: 7.996

8.  Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.

Authors:  Mark P Purdue; Mattias Johansson; Diana Zelenika; Jorge R Toro; Ghislaine Scelo; Lee E Moore; Egor Prokhortchouk; Xifeng Wu; Lambertus A Kiemeney; Valerie Gaborieau; Kevin B Jacobs; Wong-Ho Chow; David Zaridze; Vsevolod Matveev; Jan Lubinski; Joanna Trubicka; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; Péter Rudnai; Eleonora Fabianova; Alexandru Bucur; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Paolo Boffetta; Joanne S Colt; Faith G Davis; Kendra L Schwartz; Rosamonde E Banks; Peter J Selby; Patricia Harnden; Christine D Berg; Ann W Hsing; Robert L Grubb; Heiner Boeing; Paolo Vineis; Françoise Clavel-Chapelon; Domenico Palli; Rosario Tumino; Vittorio Krogh; Salvatore Panico; Eric J Duell; José Ramón Quirós; Maria-José Sanchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Kay-Tee Khaw; Naomi E Allen; H Bas Bueno-de-Mesquita; Petra H M Peeters; Dimitrios Trichopoulos; Jakob Linseisen; Börje Ljungberg; Kim Overvad; Anne Tjønneland; Isabelle Romieu; Elio Riboli; Anush Mukeria; Oxana Shangina; Victoria L Stevens; Michael J Thun; W Ryan Diver; Susan M Gapstur; Paul D Pharoah; Douglas F Easton; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Lars Vatten; Kristian Hveem; Inger Njølstad; Grethe S Tell; Camilla Stoltenberg; Rajiv Kumar; Kvetoslava Koppova; Olivier Cussenot; Simone Benhamou; Egbert Oosterwijk; Sita H Vermeulen; Katja K H Aben; Saskia L van der Marel; Yuanqing Ye; Christopher G Wood; Xia Pu; Alexander M Mazur; Eugenia S Boulygina; Nikolai N Chekanov; Mario Foglio; Doris Lechner; Ivo Gut; Simon Heath; Hélène Blanche; Amy Hutchinson; Gilles Thomas; Zhaoming Wang; Meredith Yeager; Joseph F Fraumeni; Konstantin G Skryabin; James D McKay; Nathaniel Rothman; Stephen J Chanock; Mark Lathrop; Paul Brennan
Journal:  Nat Genet       Date:  2010-12-05       Impact factor: 38.330

9.  Erratum: Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index.

Authors: 
Journal:  Korean J Urol       Date:  2011-09-28

10.  Characterisation of a novel paralog of scavenger receptor class B member I (SCARB1) in Atlantic salmon (Salmo salar).

Authors:  Hilde Sundvold; Hanna Helgeland; Matthew Baranski; Stig W Omholt; Dag Inge Våge
Journal:  BMC Genet       Date:  2011-05-30       Impact factor: 2.797

View more
  4 in total

1.  Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma.

Authors:  José-Antonio Ortiz-Rey; Carmen Fachal; Laura Juaneda-Magdalena; Mónica Muñoz-Martín; Alfredo Repáraz-Andrade; Susana Teijeira; José-María Lamas-Barreiro; Sheila Almuster-Domínguez; Pilar San Miguel-Fraile; Carolina Gómez-de María
Journal:  Virchows Arch       Date:  2021-01-14       Impact factor: 4.064

Review 2.  Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Authors:  Xiaonan Zhang; Tobias Sjöblom
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

Review 3.  Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.

Authors:  Reza Alaghehbandan; Christopher G Przybycin; Virginie Verkarre; Rohit Mehra
Journal:  Asian J Urol       Date:  2021-12-01

4.  A miRNA-based classification of renal cell carcinoma subtypes by PCR and in situ hybridization.

Authors:  Ashley Di Meo; Rola Saleeb; Samantha J Wala; Heba W Khella; Qiang Ding; Haiyan Zhai; Kalra Krishan; Adriana Krizova; Manal Gabril; Andrew Evans; Fadi Brimo; Maria D Pasic; Antonio Finelli; Eleftherios P Diamandis; George M Yousef
Journal:  Oncotarget       Date:  2017-12-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.